Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by L. Kruimer. Director active across 1 company, notably Pharming Group N.V.. Cumulatively, 16 disclosures have been published. History available since 5 August 2021. The latest transaction was disclosed on 28 May 2026 (Purchase). Regulator: AFM. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations
L. Kruimer is a declarant linked to Pharming Group N.V., where the listed role is Director or Supervisory Board. Across 15 filings in total, the 15 sampled filings cover purchases only, with total buy volume of 51321 EUR and no sales, between 2021-08-05 and 2025-06-10.